IPOMarket.com

📢 Datavault AI (NASDAQ: $DVLT) and CyberCatch ($CYBE / $CYBHF) have signed a binding LOI for Datavault AI to acquire 100% of CyberCatch in an all-stock transaction. This deal combines Datavault AI’s AI-driven data monetization and CyberCatch’s continuous cybersecurity compliance, strategically positioning Datavault AI to target major growth markets in cybersecurity, AI security, and quantum-resistant encryption. 🔐 CyberCatch’s platform provides: ✅ Continuous compliance monitoring ✅ AI-powered penetration testing ✅ Cyber Hygiene & Cyber Breach scoring ✅ Real-time threat detection and remediation The deal also strengthens Datavault AI’s quantum-secured edge infrastructure strategy across defense, healthcare, financial services, manufacturing, and energy sectors. 🔗 read the full release: bit.ly/4enEPVt #DatavaultAI #AI #DVLT #Cybersecurity #AI #QuantumComputing #DataSecurity #Compliance #NASDAQ #CYBE #CyberDefense #Fintech #GovTech #CyberCatch

Streamline Self-Funded Plans with eDIYBS With our eDIYBS system, we require only five employees to enroll. Such a small requirement number allows individuals to streamline their self-funded plans & give employees more autonomy. More via link in bio. #eDIYBS #HIT #SelfFunded

IGC Pharma Targets Alzheimer’s Agitation With New Therapeutic Approach youtu.be/PPY2CKHMUzE?si… via @YouTube

Florida vs Puerto Rico Real Estate: Taxes, Investment & Wealth Strategy ... youtu.be/8GD8vnR8n0g?si… via @YouTube @NewToTheStreet

Florida vs Puerto Rico Real Estate: Taxes, Investment & Wealth Strategy ... youtu.be/8GD8vnR8n0g?si… via @YouTube

ICONIC !!!

THE S&P 500 HAS GAINED AROUND $14 TRILLION IN MARKET CAP OVER THE PAST YEAR, UP 29.2% 📈 🟢 1 Month: +10.1% 🟢 YTD: +5.6% 🟢 1 Year: +29.2%

What a day, @NYSE to the moon, LITERALLY 😂 Incredible to have the @NASAArtemis II crew come to the floor today 🚀

📊 Scientific Research Update @TonixPharma (Nasdaq: TNXP) presents updates on its preclinical immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting continued progress in cancer research innovation. @vincemedia1 Advancing early-stage science with potential to shape future oncology treatments. Read Here👇🏻 bit.ly/Tonixpressrele… Watch the @NewToTheStreet interview here👇🏻 bit.ly/NTTS-tonixinte… 👉🏻 Learn more at bit.ly/tonixpharmaceu… #TNXP #tonixpharma #biotech #Investing #wellness #business #health #healthcare #cure #medicine #pharmacy #science #innovation #businessnews #business #news #newtothestreet

IGC Pharma Targets Alzheimer’s Agitation With New Therapeutic Approach youtu.be/PPY2CKHMUzE?si… via @YouTube @NewToTheStreet

📈 Intellectual Property Expansion @VirtuixOmni (NASDAQ: VTIX) has secured its 26th patent, further strengthening its leadership in 360-degree movement technology and immersive training systems. @vincemedia1 This milestone reinforces Virtuix’s expanding intellectual property portfolio and its continued focus on innovation, differentiation, and long-term competitive positioning in the immersive tech space. Read the full press release⬇️ bit.ly/VirtuixPressre… Watch the NewsOut feature⬇️ bit.ly/NTTS-NEWSOUTVi… Learn more at investors.virtuix.com Watch the new @NewToTheStreet interview here⬇️ bit.ly/NTTS-VirtuixRe… Follow @NewToTheStreet for the latest in tech, innovation, and business updates! #virtuix #vtix #virtualreality #gamingtech #vrtechnology #investornews #newtothestreet

🌍 Global Commercialization Expansion @GrapheneMG (TSX: GMG) announces a multi-network marketing and distribution agreement designed to accelerate global awareness and commercialization of its graphene-based technologies. @vincemedia1 The initiative expands reach across media, investor, and strategic partner networks, supporting broader market adoption and growth opportunities. Read here⬇️ bit.ly/GrapheneManufa… Learn more at graphenemg.com #GMG #graphene #cleantech #news #newtothestreet

📈 Advancing Clinical Innovation @MedicusLtd (NASDAQ: MDCX) is committed to accelerating clinical development programs for novel therapies with transformative potential. @vincemedia1 Through a focused innovation pipeline, the company is working to advance solutions that could meaningfully reshape the future of patient care and therapeutic outcomes. Learn more at medicuspharma.com Watch the @NewToTheStreet interview here⬇ bit.ly/MedicusPharmai… ➡️ Follow @NewToTheStreet for the latest in biotech, innovation, and business updates! #medicuspharma #mdcx #biotechnews #healthcare #investorrelations #innovation #marketnews #newtothestreet

What's New to The Street... Markets closed mixed after the Fed held rates steady 📊 The Dow fell 0.6%, the S&P 500 dipped slightly, while the Nasdaq managed a modest gain of less than 0.1%. @vincemedia1 Investors are now watching closely for the Fed’s next move as inflation and growth remain in focus. Share your market outlook below👇🏻 👉🏻 Follow @NewToTheStreet for daily market updates, earnings news, and investor insights. #StockMarket #SP500 #Nasdaq #DowJones #WallStreet #MarketNews #Innovation #Businessupdate #Businessnews #Business #News #Newtothestreet

📊 Upcoming KOL Event @BioVie_Pharma (NASDAQ: BIVI) will host a virtual KOL event on May 7, 2026 to discuss its Phase 2 study of Bezisterim for the treatment of Parkinson's Diseas, ahead of anticipated topline data in 2Q26. @vincemedia1 The event is expected to provide key clinical insights and expert perspectives as the company advances its pipeline in neurodegenerative disease. READ HERE⬇️ bit.ly/Bioviepressrel… Check out NewsOut Feature Here⬇️ bit.ly/NTTS-NEWSOUT-B… Check out the @NewToTheStreet ""Meet the Companies" event⬇️ bit.ly/NTTS-meettheco… Check them out here⬇️ bioviepharma.com Watch the Newest @NewToTheStreet interview here⬇️ bit.ly/NTTS-BioVieTar… #bioVie #neuroscience #medical #breakthrough #innovation #businessupdate #businessnews #business #news #newtothestreet